DNA X, Inc.
SONM
$3.94
-$0.54-12.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.66M | -33.38M | -31.14M | -30.28M | -33.65M |
| Total Depreciation and Amortization | 4.30M | 3.72M | 3.68M | 3.73M | 3.56M |
| Total Amortization of Deferred Charges | 2.07M | 4.35M | 4.35M | 6.48M | 6.48M |
| Total Other Non-Cash Items | -4.15M | -1.57M | -339.00K | -618.00K | 4.83M |
| Change in Net Operating Assets | -5.09M | 858.00K | 4.03M | 2.76M | 10.29M |
| Cash from Operations | -23.53M | -26.03M | -19.41M | -17.92M | -8.49M |
| Capital Expenditure | -- | -8.00K | -145.00K | -184.00K | -214.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -8.00K | -145.00K | -184.00K | -214.00K |
| Total Debt Issued | 6.37M | 5.11M | 2.79M | 2.84M | -- |
| Total Debt Repaid | -555.00K | -591.00K | -591.00K | -- | -- |
| Issuance of Common Stock | 13.67M | 14.01M | 9.18M | 7.54M | 4.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.49M | 19.12M | 11.97M | 10.97M | 4.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.04M | -6.92M | -7.59M | -7.14M | -4.05M |